Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard W Troughton

Showing results (11-20 of 165) with videos related to

Pageof 17
Sort By:
Heart (British Cardiac Society)|November 18, 2003
The role of echocardiography in atrial fibrillation and cardioversionRichard W Troughton, Craig R Asher, Allan L Klein
Lancet (London, England)|March 6, 2004
PericarditisRichard W Troughton, Craig R Asher, Allan L Klein
Journal of the American College of Cardiology|February 2, 2010
Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?Matthew G Daly, Christopher M Frampton, Richard W Troughton
Journal of the American College of Cardiology|December 15, 2010
Biomarker-guided treatment of heart failure: still waiting for a definitive answerRichard W Troughton, Chris M Frampton, M Gary Nicholls
Heart Failure Clinics|July 1, 2014
Natriuretic peptides in heart failure with preserved ejection fractionA Mark Richards, James L Januzzi, Richard W Troughton
The New Zealand Medical Journal|October 24, 2009
Medical image. Intracardiac slugW Y Wandy Chann, Richard W Troughton, Harsh Singh
Scientific Reports|May 15, 2020
Effect of statin therapy on plasma C-type Natriuretic Peptides and Endothelin-1 in males with and without symptomatic coronary artery diseaseTimothy C R Prickett, Richard W Troughton, Eric A Espiner
Heart (British Cardiac Society)|May 21, 2021
Preterm birth and cardiac function in adulthoodCharlotte Greer, Richard W Troughton, Philip D Adamson, et al.
Circulation|July 3, 2004
Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failureRichard W Troughton, A Mark Richards, Timothy G Yandle, et al.
Clinical Biochemistry|May 27, 2019
Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individualsJanice Chew-Harris, Sarah Appleby, A Mark Richards, et al.
Pageof 17

Showing results (11-20 of 165) with videos related to

Sort By:
Pageof 17
Heart (British Cardiac Society)|November 18, 2003
The role of echocardiography in atrial fibrillation and cardioversionRichard W Troughton, Craig R Asher, Allan L Klein
Lancet (London, England)|March 6, 2004
PericarditisRichard W Troughton, Craig R Asher, Allan L Klein
Journal of the American College of Cardiology|February 2, 2010
Improving risk stratification for heart failure. A role for serial testing of B-type natriuretic peptides?Matthew G Daly, Christopher M Frampton, Richard W Troughton
Journal of the American College of Cardiology|December 15, 2010
Biomarker-guided treatment of heart failure: still waiting for a definitive answerRichard W Troughton, Chris M Frampton, M Gary Nicholls
Heart Failure Clinics|July 1, 2014
Natriuretic peptides in heart failure with preserved ejection fractionA Mark Richards, James L Januzzi, Richard W Troughton
The New Zealand Medical Journal|October 24, 2009
Medical image. Intracardiac slugW Y Wandy Chann, Richard W Troughton, Harsh Singh
Scientific Reports|May 15, 2020
Effect of statin therapy on plasma C-type Natriuretic Peptides and Endothelin-1 in males with and without symptomatic coronary artery diseaseTimothy C R Prickett, Richard W Troughton, Eric A Espiner
Heart (British Cardiac Society)|May 21, 2021
Preterm birth and cardiac function in adulthoodCharlotte Greer, Richard W Troughton, Philip D Adamson, et al.
Circulation|July 3, 2004
Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failureRichard W Troughton, A Mark Richards, Timothy G Yandle, et al.
Clinical Biochemistry|May 27, 2019
Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individualsJanice Chew-Harris, Sarah Appleby, A Mark Richards, et al.
Pageof 17